BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
US Department of Justice
Teva
Colorcon
Chubb
AstraZeneca
Farmers Insurance
QuintilesIMS
Citi
Healthtrust

Generated: January 19, 2018

DrugPatentWatch Database Preview

GLUCOPHAGE Drug Profile

« Back to Dashboard

Which patents cover Glucophage, and what generic alternatives are available?

Glucophage is a drug marketed by Bristol Myers Squibb and is included in two NDAs. There are two patents protecting this drug.

The generic ingredient in GLUCOPHAGE is metformin hydrochloride. There are forty-eight drug master file entries for this compound. One hundred and six suppliers are listed for this compound. Additional details are available on the metformin hydrochloride profile page.
Drug patent expirations by year for GLUCOPHAGE
Pharmacology for GLUCOPHAGE
Ingredient-typeBiguanides
Drug ClassBiguanide
Medical Subject Heading (MeSH) Categories for GLUCOPHAGE

US Patents and Regulatory Information for GLUCOPHAGE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb GLUCOPHAGE metformin hydrochloride TABLET;ORAL 020357-005 Nov 5, 1998 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb GLUCOPHAGE XR metformin hydrochloride TABLET, EXTENDED RELEASE;ORAL 021202-001 Oct 13, 2000 AB1 RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb GLUCOPHAGE metformin hydrochloride TABLET;ORAL 020357-004 Nov 5, 1998 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb GLUCOPHAGE XR metformin hydrochloride TABLET, EXTENDED RELEASE;ORAL 021202-004 Apr 11, 2003 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb GLUCOPHAGE metformin hydrochloride TABLET;ORAL 020357-001 Mar 3, 1995 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb GLUCOPHAGE metformin hydrochloride TABLET;ORAL 020357-003 Nov 5, 1998 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb GLUCOPHAGE XR metformin hydrochloride TABLET, EXTENDED RELEASE;ORAL 021202-001 Oct 13, 2000 AB1 RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb GLUCOPHAGE metformin hydrochloride TABLET;ORAL 020357-002 Mar 3, 1995 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb GLUCOPHAGE XR metformin hydrochloride TABLET, EXTENDED RELEASE;ORAL 021202-004 Apr 11, 2003 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Cantor Fitzgerald
Cerilliant
Boehringer Ingelheim
Express Scripts
Dow
McKinsey
Accenture
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot